The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion

The American Journal of Cardiology

Volumn 67, Issue 2, 1991, Pages 109-115

  Kwon, Ki ik ^a   Freedman, S Benedict ^a   Wilcox, Ian ^a   Allman, Kevin ^a   Madden, Ann ^a   Carter, Grant S ^a   Harris, Phillip J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; ST SEGMENT;

COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATINE KINASE; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGE; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; RECURRENCE; STREPTOKINASE; SUPPORT, NON-U.S. GOV'T; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0025976181     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(91)90430-S     Document Type: Article

References (25)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
2. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction
3. Randomised trial of intravenous streptokinase oral aspirin both or neither among 17187 cases of suspected acute myocardial infarction ISIS-2
4. Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator
5. Intravenous streptokinase for acute myocardial infarction: effects on global and regional systolic function
6. Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction
7. The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: a 12-month follow-up report
8. Comparison of left ventricular function and contractile reserve after successful recanalization by thrombolysis versus rescue percutaneous transluminal coronary angioplasty for acute myocardial infarction
9. Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate
10. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase
11. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion
12. The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion
13. TIMI Report The thrombolysis in myocardial infarction (TIMI) trial
14. A new probability model for determining exact p-values for 2 × 2 contingency tables when comparing binomial proportions
15. Noninvasive detection of coronary artery patency using continuous ST-segment monitoring
16. Relationship between changes in ST segment elevation and patency of the infarct-related coronary artery in acute myocardial infarction
17. The electrocardiogram in patients undergoing thrombolysis for myocardial infarction
18. Factors influencing infarct size following experimental coronary occlusions
19. Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilator therapy
20. Continuous online ECG-mapping in patients with acute or impending myocardial infarction
21. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis
22. Evaluation of the effectiveness of intracoronary streptokinase infusion in acute myocardial infarction: postprocedure management and hospital course in 204 patients
23. Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase
24. Impairment of myocardial perfusion and function during painless myocardial ischemia
25. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin